Jefferies Financial Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-441,903
Closed -$1.64M 2079
2024
Q4
$1.64M Buy
441,903
+76,903
+21% +$355K 0.01% 735
2024
Q3
$2.04M Buy
365,000
+89,794
+33% +$628K 0.01% 593
2024
Q2
$2.32M Buy
275,206
+132,914
+93% +$1.42M 0.02% 502
2024
Q1
$2.05M Buy
142,292
+79,593
+127% +$1.32M 0.02% 589
2023
Q4
$1.35M Sell
62,699
-13,801
-18% -$246K 0.01% 850
2023
Q3
$1.47M Buy
76,500
+33,862
+79% +$722K 0.01% 710
2023
Q2
$1.08M Buy
42,638
+9,420
+28% +$272K 0.01% 879
2023
Q1
$1.2M Buy
33,218
+7,175
+28% +$252K 0.01% 827
2022
Q4
$1.03M Buy
+26,043
New +$1.08M 0.01% 865

Other funds holding NVRO

Jefferies Financial Group's NVRO Position: Q1 2025 in Review

Jefferies Financial Group sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 441,903 shares — an estimated $1.64M sold.

Jefferies Financial Group first reported a position in NVRO in Q4 2022 and held it in 9 quarters. The position peaked at $2.32M in Q2 2024. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • Jefferies Financial Group reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 441,903 NEVRO CORP. shares in Q1 2025, an estimated $1.64M.
  • Jefferies Financial Group first reported a position in NEVRO CORP. in Q4 2022 and held it in 9 quarters.
  • Jefferies Financial Group's NEVRO CORP. position peaked at $2.32M in Q2 2024.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.